Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix in Women With Endometriosis Recurrence
NCT01712763Phase 3Completed
- Sponsor
- Centre for Endocrinology and Reproductive Medicine
- Start
- Nov 2012
- Primary completion
- Mar 2016
- Modality
- Peptides, Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised trial of degarelix in endometriosis, sponsored by Centre for Endocrinology and Reproductive Medicine. Primary endpoint: Disease-free time at 24 months. Started Nov 2012; status: completed.
02
Drugs
degarelix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT01712763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01712763.